bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Aligos Therapeutics Inc. logo

    Aligos Therapeutics Inc.

    ALGS | NASDAQ
    Chart Builder DCF Calculator
    $5.79
    +$0.30 (+5.46%)
    Sep 22, 2026, 2:29 PM ET · Market open
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $33.97M
    Enterprise Value
    $8.09M
    Beta
    2.33
    Average Volume
    158.45K
    Shares Outstanding (Diluted)
    10.43M
    Shares Change YoY
    0.77%
    Institutional Ownership
    26.68%
    Exchange
    NASDAQ
    ISIN
    US01626L2043

    Price Performance

    Price Change 1M
    -14.9%
    Price Change 3M
    0.0%
    Price Change 6M
    -18.8%
    Price Change YTD
    -38.1%
    Price Change 1Y
    -40.7%
    Price Change 3Y
    -70.3%
    Price Change 5Y
    -98.6%
    1M CAGR (ann.)
    -1.8%
    1Y CAGR (ann.)
    -45.0%
    5Y CAGR (ann.)
    -57.4%
    All-Time CAGR
    -50.8%

    Valuation

    PE Ratio
    -0.77
    Forward PE
    N/A
    PEG Ratio
    0.00
    Forward PEG
    0.04
    PS Ratio
    1.11
    Forward PS
    8.60
    PB Ratio
    1.10
    P/FCF Ratio
    -0.37
    P/Adj. FCF Ratio
    -0.35
    P/OCF Ratio
    -0.63
    EV/Sales
    0.26
    EV/EBIT
    -0.11
    EV/EBITDA
    -0.11
    EV/FCF
    -0.09
    Earnings Yield
    -129.2%
    FCF Yield
    -270.4%
    Adj. FCF Yield
    -286.4%

    Financial Health

    Net Cash
    $30.38M
    Total Debt
    $3.5M
    Cash & Short-Term Investments
    $30.38M
    Total Assets
    $66.33M
    Current Ratio
    2.19
    Quick Ratio
    2.19
    Debt / Equity Ratio
    0.11
    Debt / EBITDA
    -0.05
    Debt / FCF
    -0.04
    OCF / Debt
    -26.87
    Interest Coverage
    0.00
    Altman Z-Score
    -16.01
    Piotroski F-Score
    2

    Margins & Profitability

    Gross Profit Margin
    99.2%
    Operating Profit Margin
    -250.6%
    EBITDA Margin
    -225.9%
    Net Profit Margin
    -241.0%
    FCF Margin
    -299.9%
    Adj. FCF Margin
    -317.7%
    SBC / Revenue
    17.8%
    SBC Impact (per share)
    -5.9%

    Returns

    Return on Assets
    -114.5%
    Return on Equity
    -160.7%
    Return on Invested Capital
    -191.7%
    Return on Capital Employed
    -208.0%
    Return on Tangible Assets
    -114.5%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    22.3%
    Revenue CAGR 5Y
    66.6%
    Revenue CAGR 10Y
    N/A
    EPS CAGR 3Y
    -28.3%
    EPS CAGR 5Y
    -34.9%
    EPS CAGR 10Y
    N/A
    FCF CAGR 3Y
    -5.4%
    FCF CAGR 5Y
    2.9%
    FCF CAGR 10Y
    N/A

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    5
    EPS Growth Next 3Y
    35.9%
    Revenue Growth Next 3Y
    78.1%
    Earnings Date
    Nov 4, 2026
    EPS Estimate (next Q)
    -$2.44
    EPS Growth Est (next Q)
    -19.7%
    Revenue Est (next Q)
    $4.85M
    Revenue Growth Est (next Q)
    554.5%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $20
    Price Target Upside
    254.0%

    Cash Flow

    Operating Cash Flow
    $-94.17M
    Free Cash Flow
    $-94.52M
    Adj. Free Cash Flow
    $-100.13M
    FCF Per Share
    -$9.06
    OCF Per Share
    -$9.03
    OCF/S Ratio
    -298.8%

    Income Statement

    Revenue
    $31.52M
    Gross Profit
    $31.26M
    Operating Income
    $-78.99M
    EBITDA
    $-71.19M
    Net Income
    $-75.96M
    EPS (Diluted)
    -$7.30
    Revenue / Employee
    $384.37K
    Profit / Employee
    $-926.37K
    Employees
    82

    © 2026 bestshares.com. All rights reserved.